Skip to main content
Figure 3 | Breast Cancer Research

Figure 3

From: Changes in expression of oestrogen regulated and proliferation genes with neoadjuvant treatment highlight heterogeneity of clinical resistance to the aromatase inhibitor, letrozole

Figure 3

Heterogeneity of endocrine-resistant tumours. Heatmap illustrates changes after 10 to 14 days of treatment with Letrozole: Green represents a decrease in mRNA expression, red represents an increase in mRNA expression, brightness of colour corresponds to the degree of changes. Scale in log to the base 2.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us